Polycystic Ovary Syndrome Clinical Trial
Official title:
Iyengar Yoga for Treatment of Endometriosis and Secondary Dysmenorrhea: A Randomized Controlled Clinical Trial
The purpose of this clinical trial is to look at the effectiveness of prescribing yoga
classes to patients with dysmenorrhea (irregular or painful periods), or other menstrual
disorders on patients' self reported pain and quality of life.
Patients will be recruited from primary care clinics around Illinois, including Carle
Hospital. This is a randomized trial in which patients will first be randomized into the
control or intervention group. Patients in the control group will undergo usual care and be
surveyed at baseline, 3 months, 6 months and 9 months. Patients in the control group will be
offered the 3 months of yoga therapy complimentary after completing the 9 month control.
Control patients who choose to participate in the yoga therapy will be asked to also complete
the surveys at the end of the 3 month yoga intervention. Patients in the intervention group
will first undergo 3 months of regular care and then 3 months of biweekly yoga classes.
Participants will complete surveys at baseline, 3 months (after of control care), 6 months
(after 3 months of biweekly yoga classes), 9 months, and 12 months (after 6 months of
observation and optional yoga practice).
Participants will contact the research team with the information on the flyer. Participants
will be asked to come to the Iyengar Yoga Center (407 W Springfield Ave, Urbana, IL 61801) to
receive more information. Participants will need to disclose their diagnosis to the research
staff. If they are not aware of what their diagnosis is, they will need to contact their
physician to get their official diagnosis. For example, a woman with dysmenorrhea may be
diagnosed with poly cystic ovarian disease or endometriosis or idiopathic dysmenorrhea, or
another reproductive disease; participants will need to know their specific diagnosis or find
out their specific diagnosis and report it to the research staff. Participants can do this by
calling their physicians. For participants that are unaware of their diagnosis, they may also
request a copy of their medical records. These records may be shared with the research staff
to help determine diagnosis. The research staff will not keep these medical records, but
return them to the participants. Participants can then either consent on the first visit or
choose to take time as much time as they need and return to the yoga center when they are
ready to sign the consent form. Participants will complete the first round of surveys at the
yoga center after they sign the consent form (20 minutes). Participants will receive an email
or phone call from the study team to inform them of their randomization results.
A blind third party statistician will complete the randomization for all participants at the
beginning of the study for all 90 participants and will email the study coordinator with the
randomization results. Randomization will be done through a free online software called
graphpad. (https://www.graphpad.com/quickcalcs/randomize1.cfm).
The study lasts 12 months for the intervention and 9 months for the control group with an
optional 3 month yoga therapy session offered at the end: Once consented, participants will
fill out baseline surveys, and then undergo 3 months of usual care (no intervention), the
same baseline surveys will be filled out again, then participants will get biweekly free yoga
therapy classes for 3 months, and surveys will again be completed at the end of the
intervention. Patients will then have a 6 month follow up and will fill out the surveys one
last time. Recruitment will occur on a rolling basis so patients may join the study at
anytime and not have to wait for a batched group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT06158932 -
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Completed |
NCT04932070 -
Berberine and Polycystic Ovary Syndrome
|
N/A | |
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT03480022 -
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
|
Phase 3 | |
Active, not recruiting |
NCT03043924 -
Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT05246306 -
Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
|
||
Completed |
NCT05981742 -
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
|
Phase 2 | |
Completed |
NCT05702957 -
Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT05029492 -
Effect of Visceral Manipulation on PCOS
|
N/A | |
Completed |
NCT02924025 -
Motivational Interviewing as an Intervention for PCOS
|
N/A | |
Not yet recruiting |
NCT02255578 -
Endobarrier Treatment in Women With PCOS
|
Phase 3 | |
Not yet recruiting |
NCT00883259 -
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
|
Phase 4 | |
Withdrawn |
NCT01638988 -
Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin
|
Phase 3 | |
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Completed |
NCT01462864 -
Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome
|
N/A | |
Recruiting |
NCT01431352 -
Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT00989781 -
Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome
|
N/A |